Introduction {#sec1}
============

Asthma is an important health problem. Its prevalence is increasing worldwide, especially in low and middle income countries.[@bib1] The Global Burden of Disease 2015 estimated that nearly 400 million people around the world suffer from this condition. Asthma is considered as the 11th highest cause of Years Lived with Disability (YLDs) worldwide.[@bib2], [@bib3]

Allergic Rhinitis (AR) is a disease the prevalence of which is increasing in a similar fashion to that of asthma.[@bib1] It affects 10--30% of the general population and is suspected to be a risk factor for onset of asthma in several epidemiologic studies.[@bib4], [@bib5], [@bib6], [@bib7] However, most studies of this relation are of a cross-sectional nature, a design that could prove inadequate for causal inference. Furthermore, the remaining case-control and cohort studies evaluating this association show effect estimates the magnitude of which vary considerably from study to study, swaying between absence of statistically significant association,[@bib8] and extremely strong relationships.[@bib9] Yet in 2012, the ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines stated that sophisticated statistical methods should be implemented in order to have a more objective view of the link between AR and asthma.[@bib10]

To provide a global assessment and a quantitative summary of the association between AR and asthma, we performed a systematic review and meta-analysis of cohort and case-control studies.

Methods {#sec2}
=======

Search strategy {#sec2.1}
---------------

We searched MEDLINE via Pubmed, Scopus, the Conference Proceedings Citation Index-Science (CPCI--S) database, the Open Access Theses and Dissertations (OATD), and the 5 regional bibliographic databases of the World Health Organization (WHO) (African Index Medicus, Latin American and Caribbean Health Science Literature Database, Index Medicus for the Eastern Mediterranean Region, Index Medicus for South-East Asia Region, Western Pacific Region Index Medicus), from inception of each database to the end of February 2019, without any language limitation. The search strategy was as follows: (((((\"Rhinitis, Allergic, Seasonal\"\[Mesh\]) OR (\"Rhinitis, Allergic\"\[Mesh\]) OR \"allergic rhinitis\" OR rhinitis)))) AND ((\"Asthma\"\[Mesh\]) OR asthma) AND ((((\"Case-Control Studies\"\[Mesh\]) OR \"Cohort Studies\"\[Mesh\]) OR case-control) OR cohort) for Medline and equivalent wording in other databases. Due to the nature of exposure, rhinitis, our meta-analysis had to be based on observational studies only, in spite of their limitations. No experimental studies can be carried out on this topic. To find any additional published study, the reference lists of all retrieved articles and related review articles were searched manually. All searches were performed by two independent reviewers (HRT and NM) and disagreements about inclusion of some studies were resolved by consensus and, when needed, by consulting with a third party (BT). The review protocol was registered in PROSPERO with registration number CRD42017055156.

Inclusion criteria {#sec2.2}
------------------

Case-control and cohort studies were included if: 1) the main or secondary outcome was asthma, 2) the exposure of interest or one of the covariates was allergic rhinitis, 3) they reported a measure of association between allergic rhinitis and asthma such as Risk Ratio, Rate Ratio, Odds Ratio and their variance, standard error or 95% confidence intervals (CI), or provided enough raw data to calculate them. Whenever necessary, we contacted the authors to provide more information for the calculation of the effect measure or to clarify some methodologic aspects of the study.[@bib11], [@bib12], [@bib13], [@bib14] Studies without comparison group (allergic rhinitis-free in cohort studies and asthma-free in case-control studies) and those that did not report measures of effect nor provide enough information for calculating them were excluded.[@bib13] If a study did not adjust for any factor, this study was not excluded but instead, we used its crude estimate.[@bib8], [@bib15] In case of duplication of a publication, we included the most complete one. When we were unable to assess whether two publications were from the same study, we contacted their authors to consult about this issue.[@bib7], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21]

Data extraction {#sec2.3}
---------------

Data were extracted using a predefined form with the following information: first author, year of publication, country, study design, source of data, type of population, number of participants, mean age of participants, measure of association, and adjustment, restriction or matching factors. The data were extracted following the same procedure as that used for the bibliographic searches. The extraction was carried out independently by 2 authors and discrepancies were resolved by consensus.

Quality assessment {#sec2.4}
------------------

We assessed the quality of the studies using a modified version of the Newcastle-Ottawa scale that we adapted to the needs of this meta-analysis. We used a common quality assessment form for both case-control and cohort studies to be able to use their score in a comprehensive fashion. We first performed an analysis based on the global score and then subsequent analyses based on each criterion. The following 5 criteria were considered on a yes/no basis: 1) whether the target population was clearly defined or just based on convenience sampling, 2) whether asthma diagnosis is based on clinical features and spirometry (flow rate) and/or reversal after treatment or was only based on clinical examination, 3) whether rhinitis diagnosis is based on clinical and lab examination or was based on questionnaire only, 4) whether or not asthma symptoms clearly occurred after rhinitis onset, and 5) whether or not results were adjusted for age, sex and family history of asthma. Each item was scored as 0 or 1. Quality assessment was independently conducted by two investigators (HRT and NM) and disagreements were solved by a third investigator (BT).

Statistical methods {#sec2.5}
-------------------

Risk Ratios and Rate Ratios in cohort studies and Odds Ratios in case control studies were considered as measures of effect in this meta-analysis. Odds Ratios from case-control studies were assumed to be unbiased estimates of the Rate Ratios.[@bib22] Heterogeneity among studies was evaluated via the Ri statistic (the proportion of total variance due to between-studies variance)[@bib23] as well as the DerSimonian & Laird Q test, in which a p-value\<0.1 was considered as statistically significant. For pooling the effect size estimates, the inverse of variance was considered as the weight for each study. We computed both fixed effects and random effects estimates, but as heterogeneity was frequent in subgroup analyses, we presented random effects data only. For each study we used the estimate that was adjusted for the largest number of variables.

We performed subgroup analysis according to the design of studies, region, age group, quality score, and items of quality assessment. Cumulative meta-analysis was conducted to identify any trend in estimates across time. The Begg\'s rank correlation test and the Egger regression test were used to statistically assess publication bias. We also visually assessed publication bias using a funnel plot and performed the Trim-and-Fill procedure to estimate the number of potential missing studies in our meta-analysis and their effect on the outcome.[@bib24] HEpiMA software[@bib25] and STATA 12 (Stata Corp, College Station, TX, USA) were used for statistical analysis.

Results {#sec3}
=======

We found a total of 29 eligible studies, including 22 cohort studies and 7 case-control studies with a total of 274,489 subjects.[@bib6], [@bib7], [@bib8], [@bib9], [@bib11], [@bib12], [@bib15], [@bib16], [@bib26], [@bib27], [@bib28], [@bib29], [@bib30], [@bib31], [@bib32], [@bib33], [@bib34], [@bib35], [@bib36], [@bib37], [@bib38], [@bib39], [@bib40], [@bib41], [@bib42], [@bib43], [@bib44], [@bib45]

Twenty one studies were conducted in European countries and 8 in non-European countries between 1994 and 2019. Except for 2 articles published in Spanish[@bib44] and German,[@bib9] the rest were written in English. One article comprised 2 independent case-control studies carried out in different countries. We, therefore, considered these 2 studies separately.[@bib45] Among the studies that could have been potentially included in our meta-analysis, we excluded 3 articles[@bib17], [@bib18], [@bib19] because of overlap of data with a more comprehensive study.[@bib7] Furthermore, we found 3 articles from the same author,[@bib16], [@bib20], [@bib21] 2 of which were excluded after consulting with the author.[@bib20], [@bib21] We also excluded 1 conference abstract,[@bib46] as after contacting the authors, we were informed that the corresponding study was published later as a full paper in another language.[@bib9] One study was excluded as we could not trace its authors to collect the necessary information to calculate effect measures.[@bib13] Data from 2 studies were obtained through contact with the authors.[@bib11], [@bib12] We did not find any relevant study published in a book or dissertation. The main characteristics of the remaining 29 studies included in this meta-analysis are summarized in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}. The flow diagram presenting the screening process and the reasons for exclusion is presented in [Fig. 1](#fig1){ref-type="fig"}[@bib47]Table 1Main characteristics of cohort studies included in the meta-analysis of association between allergic rhinitis and asthma.Table 1Author (Year)CountrySource of dataNº of cases of asthma/cohort sizeNº of allergic rhinitis patientsAge at start of cohortFollow-up durationRR (95%CI)Adjusting or matching variablesSegura-Navas et al. (2018)[@bib40]SpainCohort of schoolchildren in Castellón, Spain44/128010613--15 years10 years4.05 (1.71--9.60)Age, sex, family history asthma, family history of allergic rhinitis, history of respiratory diseases, breastfeeding, living place, passive smoking, mother\'s age at time of birth, and pet at homeMoshe et al. (2015)[@bib41]IsraelAll-male Israel Defense Forces (IDF)[a](#tbl1fna){ref-type="table-fn"}1984/128591489118--21 years3 years1.86 (1.57--2.21)SexTormanen et al. (2018)[@bib42]FinlandCohort of infant hospitalized for bronchiolitis18/13839less than 6 months11--13 years4.06 (1.35--12.25)Age, maternal asthma, maternal allergy, parental asthma, paternal allergy, maternal and paternal smokingCarr et al. (2019)[@bib43]USATucson Children\'s Respiratory Study (TCRS)117/521876 years26 years3.7 (2.2--6.1)age, sex, ethnicity, maternal asthma, maternal education, maternal smoking at enrolment, and history of 4 + colds per yearArnedo et al. (2007)[@bib44]SpainCohort of schoolchildren in Castellón108/16981076--7years8 years3.21 (l.45--7.09)Age, sex, family history of asthma, family history of allergic rhinitis, history of bronchitis, mother\'s age, other respiratory diseases, passive smoking, pet at home, social class.Verlato et al. (2016)[@bib27]ItalyItalian Study on Asthma in young Adults (ISAYA) and Italian Study on the Incidence of Asthma (ISIA)145/524151720--54 years9 years4.00 (3.68--4.35)Age, sex, occupation, asthma-like symptoms, chronic bronchitis, smokingYeh et al. (2016)[@bib12]TaiwanNational Health Insurance Research Database187/7599213035--65 years11 years1.84 (1.38--2.45)Age, sex, co-morbiditiesPallasaho et al. (2011)[@bib28]FinlandFinEsS study, Helsinki157/6062138720--69 years11 years2.00 (1.40--2.87)Age, sex, family history of asthma, smokingRochat et al. (2010)[@bib29]GermanyGerman Multicentre Allergy Study (MAS) birth cohort.50/1314178013 years6.46 (2.93--14.23)Age, sex, study center, parental atopy, parental education, maternal smoking during pregnancy, siblingshipEkerljung et al. (2008)[@bib31]SwedenRandom sample of general population from Stockholm159/4479Not given20--69 years10 years2.21 (1.41--3.48)Age, sex, family history of asthma, smokingShaaban et al. (2008)[@bib7]14 European countriesEuropean Community Respiratory Health Survey (ECRHS)140/6461121720--44 years9 years3.53 (2.11--5.91)Age, sex, country, body mass index, IgE, FEV1, family history of asthma, history of respiratory infection, smokingRzehak et al. (2008)[@bib30]GermanyBitterfeld study142/31991245--13 years12 years4.34 (2.73--6.9)Age, sex, parental asthmaMorais-Almeida et al. (2007)[@bib32]PortugalHospital database70/3081566 month-6 year old8 years15.76 (6.1--40.8)Parental asthma, history of atopic eczema, history of food allergy, attendance of kindergarten, IgE, age of onset of symptoms, allergen sensitizationBurgess et al. (2007)[@bib37]AustraliaTasmanian Asthma Study299/858310617 years37 years3.16 (2.46--4.05).Age, history of allergy, impaired lung function, socioeconomic statusPorsbjerg et al. (2006)[@bib8]DenmarkCivil Registry45/291387--17 years12 years1.7 (0.70--3.90)NoneThomsen et al. (2005)[@bib16]DenmarkDanish Twin Registry838/19349166712--41 years8 years3.90 (3.31--4.61)SexPolosa et al. (2005)[@bib38]ItalyUniversity Allergy Clinic database161/43633218--40 years10 years7.81 (3.05--20.04)Sex, family history of allergy, pet ownership, sensitization to allergens, parental smoking at homeRonmark et al. (2002)[@bib34]SwedenObstructive Lung Disease in Northern Sweden (OLIN) studies51/32471567--8 years2 years5.91 (2.76--12.65)Sex, family history of asthma, respiratory infections, breast feeding, mother\'s smoking, pets, dampnessLinneberg et al. (2002)[@bib11]DenmarkCopenhagen Allergy Study48/1112Not given15--69 years8 years9.3 (4.38--19.74)Age, sexHuovinen et al. (1999)[@bib39]FinlandFinnish Twin Cohort Study261/1154065618--45 years15 years3.14 (1.61--6.12)Age, sex, dizygotic/monozygoticStrachan et al. (1996)[@bib36]England, Scotland and WalesBritish 1958 cohort study2488/185591855033 years1.42 (1.33--1.51)Age, sex, maternal age, birth order, social class, smoking, gestation, albuminuria, bleeding in pregnancy, history of pneumonia, whooping cough, tonsillectomy, eczema, abdominal pain, vomiting, and migraine.Settipane et al. (1994)[@bib15]USABrown University cohort study97/183616218 years23 years2.92 (1.55--5.48)None[^1]Table 2Main characteristics of case-control studies included in the meta-analysis of association between allergic rhinitis and asthma.Table 2Author (Year)CountrySource of dataCases/controlsNº of allergic rhinitis patientsAge Mean ± SDOR (95%CI)Adjusting or matching variablesJacob et al. (2016)[@bib6]GermanyGerman pediatricians database34305/34305244636--17 years5.38 (5.17--5.59)Age, sex, co-morbiditiesCoelho et al. (2016)[@bib26]BrazilStudents registered in Family Health Strategy (FHS) program172/3793266--14 years3.35 (2.24--5.01)Pets, passive smoking, consumption of cooked vegetables, consumption of fish, history of eczema, family history of allergy, skin tests for immediate hypersensitivity (STIH)Tomic Spiric et al. (2007)[@bib9]SerbiaHospital database134/134Not givenCases: 38.96 ± 12.37 years\
Controls: 39.37 ± 12.38 years30.74 (7.62--123.98)Age, sex, living place, outpatient/inpatient status, history of childhood lower respiratory infection, SinusitisGuerra et al. (2002)[@bib35]USATucson Epidemiologic Study of Obstructive Lung Diseases173/21771086Cases: 50.81 ± 19.3 years\
Controls: 52.96 ± 21.2 years3.21 (2.19--4.71)Age, sex, atopic status, smoking status, presence of COPDToren et al. (2002)[@bib33]SwedenMAP-study235/2044104Cases:39.6 ± 0.82 years\
Controls: 36.9 ± 0.1 years4.8 (3.4--6.7)Age, atopy, year of diagnosisSzentpetery et al. (A) (2017)[@bib45]Puerto RicoPopulation-based case control312/29767Age range: 6--14 years; Cases: 10.06 ± 2.6 years\
Controls: 10.51 ± 2.7 years3.9 (1.9--7.6)Age, sex, household income, parental asthma, early life second hand smoking, obesity, diet, lifetime exposure to gun violence.Szentpetery et al. (B) (2017)[@bib45]SwedenThe Children, Allergy, Milieu, Stockholm, Epidemiological Survey \[BAMSE\] Study121/216932Cases: 12.92 ± 0.77\
Controls: 12.97 ± 0.837.8 (3.5--17.6)Age, sex, parental asthma, early life second hand smoking, obesity[^2]Fig. 1Flow diagram of study selection in systematic review and meta-analysis of history of allergic rhinitis and risk of asthmaFig. 1

Association of allergic rhinitis and asthma {#sec3.1}
-------------------------------------------

After pooling the data using the random effect model, we observed that history of allergic rhinitis is strongly associated with asthma (pooled Odds Ratio = 3.82; 95% CI: 2.92--4.99). Subgroup analysis showed that this association was weaker for non European studies (OR = 2.75; 95% CI: 2.16--3.50) than for European studies (OR = 4.35; 95% CI: 3.12--6.06). Although the association was significant in both designs, case-control studies showed a stronger association (OR = 4.71; 95% CI: 3.58--6.17) than cohort studies (OR = 3.42; 95% CI: 2.60--4.50). The association was similar in studies with low and high quality scores (OR = 3.86; 95% CI: 2.49--6.00 versus 3.61; 95% CI: 2.97--4.39, respectively), while studies on children showed a stronger relation (OR = 4.10; 95% CI: 2.56--6.56) than those conducted on adults (OR = 3.37; 95% CI: 2.64--4.30). The detailed information as well as results of other subgroup analyses are presented in [Table 3](#tbl3){ref-type="table"}. In all analyses (overall and subgroups) there was evidence of heterogeneity between studies ([Table 3](#tbl3){ref-type="table"}, [Fig. 2](#fig2){ref-type="fig"}). Based on the proportion of total variance due to between-study variance, this heterogeneity was low for studies with full adjustment and moderate for the following subgroups: case-control studies, good quality studies, non-European studies and studies with adequate diagnosis of asthma and rhinitis, while this heterogeneity was high for the rest of subgroups.Table 3Random effects Pooled Odds Ratios (ORs) and 95% confidence intervals (CIs) of allergic rhinitis and asthma in different subgroups.Table 3GroupsNumber of studiesOR (95% CI)Ri[a](#tbl3fna){ref-type="table-fn"}p- value of Q test**All studies**293.82 (2.92--4.99)0.98\<0.001**Design** Cohort studies223.42 (2.60--4.50)0.96\<0.001 Case-control studies74.71 (3.58--6.17)0.700.003**Region** European214.35 (3.12--6.06)0.98\<0.001 Non European82.75 (2.16--3.50)0.73\<0.001**Age group** Children154.10 (2.56--6.56)0.99\<0.001 Adults143.37 (2.64--4.30)0.89\<0.001**Quality Score** \<3113.86 (2.49--6.00)0.99\<0.001 ≥3183.61 (2.97--4.39)0.510.006**Items of quality assessment:Proper definition of target population** Yes233.42 (2.62--4.48)0.96\<0.001 No66.26 (3.18--12.30)0.97\<0.001**Proper diagnosis of asthma** Yes93.67 (2.52--5.34)0.81\<0.001 No203.82 (2.92--4.99)0.98\<0.001**Proper diagnosis of Allergic Rhinitis** Yes125.06 (3.58--7.15)0.640.001 No173.18 (2.26--4.46)0.99\<0.001**Clear temporal trend between rhinitis and occurrence of asthma** Yes243.55 (2.74--4.61)0.96\<0.001 No54.89 (3.26--7.35)0.680.015**Adjustment** Full adjustment123.82 (2.92--4.98)0.430.057 Incomplete adjustment173.94 (2.77--5.61)0.99\<0.001[^3]Fig. 2Forest plot of the association between history of allergic rhinitis and risk of asthma (random effects)Fig. 2

Publication bias {#sec3.2}
----------------

The funnel plot of effect size of the studies was slightly skewed to the right ([Fig. 3](#fig3){ref-type="fig"}), and the Begg\'s test (p-value = 0.023) provided some evidence for the presence of small-study effects. However, the Egger\'s test showed no evidence of publication bias (p-value = 0.66). The Trim-and-Fill procedure did not impute any study when we applied the random effects model, while one study was imputed when the fixed effects model was used. The pooled OR after inclusion of this study was 3.67 (95% CI: 3.56--3.78), very close to the original pooled OR of 3.82 (95% CI: 2.92--4.99).Fig. 3Funnel plot of association between history of allergic rhinitis and risk of asthmaFig. 3

To evaluate the possibility of publication bias in case--control studies, the design most susceptible to be rejected by journals when results lack statistical signification, we recalculated our pooled estimates under the following extreme assumptions: 1) published studies listed in [Table 2](#tbl2){ref-type="table"} are only half of the case-control studies on allergic rhinitis and risk of asthma ever conducted, 2) all studies of the unpublished half found null associations (ie, OR = 1) between allergic rhinitis and asthma, and 3) on average, the unpublished studies included as many cases and controls as the published ones. Under these assumptions, the observed pooled OR was 2.89 (95% CI: 2.19--3.81) that was still large enough to support the findings of our study.

We performed another simulation to evaluate the robustness of our results to the publication bias. We calculated how many unpublished negative (OR = 1) case-control studies with as many cases and controls as the average number of the published studies were necessary to reverse our conclusions. Our simulation showed that 187 negative studies were needed to obtain a pooled OR of 1.10 (95% CI: 1.06--1.14) and 945 studies to obtain an OR of 1.01 (95% CI: 1.003--1.018).

Cumulative meta-analysis {#sec3.3}
------------------------

Cumulative meta-analysis by year of publication showed that the first stable and statistically significant effect was observed after including the study by Huovinen et al. published in 1999 (pooled OR = 2.19; 95% CI: 1.19--4.04).[@bib39] The pooled OR increased up to a value of 3.46 (95% CI: 1.62--7.39) after adding the study of Linneberg et al., in 2002,[@bib11] but subsequent studies did not change the strength of association in a meaningful fashion and just increased the precision of the pooled estimate ([Fig. 4](#fig4){ref-type="fig"}).Fig. 4Cumulative forest plot of the association between history of allergic rhinitis and risk of asthmaFig. 4

Discussion {#sec4}
==========

Our meta-analysis showed that allergic rhinitis is associated with the occurrence of asthma. This association was observed in all subgroups, albeit with different magnitudes. A plausible explanation of this association is provided by the "atopic march" hypothesis that considers atopic disorders as a series of consecutive clinical manifestations which start with atopic dermatitis, follow with allergic rhinitis, and end up with asthma as sensitizations in upper and lower airways, respectively.[@bib48] A similar view is represented by the "one airway, one disease" concept, in which AR and asthma are believed to be but one unique disease.[@bib49]

In a study in human subjects, Braunstahl et al. revealed that the provocation of nasal mucosa with allergens results in an increase in lower airways eosinophilia in patients with AR.[@bib50] In addition, the increase in the risk of asthma after exposure to AR is supported by some experimental animal studies. Li et al. showed that exposure of nasal mucosa to allergens increases the concentration of factors that are related to asthma such as eosinophils, interleukin-5 and CD34 cells in peripheral blood and bone marrow in mice.[@bib51]

Another explanation of the relation of allergic rhinitis and asthma could be represented by the existence of a common cause for these two diseases, which affects upper and lower airways in different periods and could play a role of confounder in this association. Some studies showed that polymorphisms in the filaggrin gene, such as R501X and 2282del4, are related to both AR and asthma.[@bib52], [@bib53] Also, inhalant allergens, such as pollen, pets, house dust mites, and moulds could be predictors of AR and asthma. Nevertheless, the existence of a strong confounder that could explain the total of the association observed is unlikely. Even if this unidentified factor (either a polymorphism or an environmental factor) could multiply by 5 the risk of asthma among subjects exposed to it (Relative Risk confounder--disease = 5) and, at the same time, this factor is 5 times more prevalent among people suffering from AR than among the rest of the population (Relative Risk confounder--exposure = 5), the adjusted Relative Risk of the relation rhinitis-asthma would still be 2.30 (assuming one-third of people are exposed to this unknown factor).[@bib54] The existence of a factor so strongly associated with rhinitis on one side, and with asthma on the other side, is highly improbable.

This meta-analysis showed a large amount of heterogeneity that persisted after stratification in subgroups. We therefore focused our interpretation on the random effects estimates as recommended.[@bib55], [@bib56] Meta-analysis experts claim that there is no amount of heterogeneity that is unacceptable provided the eligibility criteria are sound and the data are correct,[@bib55] and that heterogeneity in meta-analysis, due to the differences in methods and populations, should be viewed as the "expectation, rather than the exception".[@bib57]

Publication bias is unlikely to happen in this meta-analysis because the association remained strong even after extremely conservative assumptions about the potentially related but unpublished studies. In addition, although the Begg\'s test showed some evidence of publication bias, Egger\'s test did not confirm it and the Trim-and-Fill procedure did not modify the results obtained previously. Furthermore, to prevent this bias, we conducted a thorough electronic and manual search, without any language restriction, in virtually every available database that could provide articles, dissertations, and conference abstracts.

Furthermore, the results observed do not depend on the intrinsic quality of the studies as the magnitude of the association is similar among studies deemed to be of high quality and studies with a lower quality score.

To the best of our knowledge, this study is the first meta-analysis on this topic. However, there are previous narrative reviews which have not retrieved all related studies or which have included cross sectional studies, a type of studies which cannot provide reliable evidence for cause-effect relationship due to its inability to assess a temporal trend between the occurrence of AR and that of asthma. To avoid this bias, our meta-analysis excluded cross-sectional designs and used cohort and case-control studies only.

In conclusion, the magnitude of the associations, and the consistency of the results in different settings provide strong epidemiological evidence that people with allergic rhinitis have a higher odds of asthma occurrence than healthy people. Further prospective studies on the effect of treatment of allergic rhinitis on the development of asthma are needed. Relief of airway allergic manifestations may need dual control of allergic rhinitis and asthma.
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